---
title: Elamipretide — pending — pending
record_id: elamipretide
reviewed_at: 2026-07-23
lane: approved
dataset_version: 2026-07-23.1
schema_version: 1.1.0
---

# Elamipretide

**Exact identity:** pending; pending; pending; intended use: human use (unspecified).

## Current answer

Elamipretide has FDA-approved prescription products (Forzinity (NDA 215244)). CompoundedGuide is verifying compounding status, safety signals, and current evidence. This is not medical advice.

## Status

- Product status: FDA-approved: Forzinity (NDA 215244)
- Compounding status: Not verified
- Evidence tier: FDA-approved product exists
- Commercial policy: none

## Uncertainty

- FDA approval status verified via Drugs@FDA.
- Compounding status, shortage status, and safety profile are not yet verified.
- This is not a medical, legal, or professional endorsement.

## Sources

- [Drugs@FDA](https://www.accessdata.fda.gov/scripts/cder/daf/) — P0, retrieved 2026-07-24T00:00:00Z

## Machine record

- Canonical HTML: https://compoundedguide.com/peptide/elamipretide/
- JSON: https://compoundedguide.com/api/records/elamipretide
- Schema: https://compoundedguide.com/schemas/peptide-record/v1.json
- Dataset manifest: https://compoundedguide.com/datasets/peptide-status-registry/manifest.json